Crossmark

Modulation of the Gut Microbiome to Enhance Immunotherapy Response in Metastatic Melanoma Patients: A Clinical Review

Published Online: 2022-09-25

Published Print: 2022-11

Authors

Najmi, Maleka https://orcid.org/0000-0002-3833-5936
Tran, Tiffaney

Witt, Russell G.

Nelson, Kelly C.
Funding

Funding for this research was provided by:

Melanoma Research Foundation grant

National Institutes of Health T32 grant

MD Anderson Cancer Center support grant

Lyda Hill Foundation
License Information

Text and Data Mining valid from 2022-09-25

Version of Record valid from 2022-09-25
More Information

Article History

Received: 26 July 2022

Accepted: 5 September 2022

First Online: 25 September 2022

Document is current